Brampton, ON, June 25, 2019: Today, 1 in 9 adults aged 20 and older—more than three million Canadians—lives with diagnosed diabetes. Approximately 90% of these cases are type 2 diabetes, which is a preventable form of diabetes for many Canadians. Although diabetes...
This month, our newest publication is the full report of the Eversense study results. Eversense is the very nifty sensor that is implanted subcutaneously and provides continuous glucose monitoring to your phone for 6 months. Our results were in teenagers – the...
Using RWD and RWE to make data actionable and patient centric can be a gamechanger in the health care industry’s research capabilities. During ACRP 2019, Karri Venn, president of research at LMC Manna, gave a talk regarding real world data (RWD) and real world...
LMC Manna Research’s Chief Medical officer Dr. Ronnie Aronson shares our latest publication showcasing our collaborative work with the medications lixisenatide and LixiLan (lixisenatide & lantus combination) over the past decade. This publication is a post-hoc...
With one month of 2019 already completed, we are excited to share a 2nd FIT published paper from LMC Manna Research’s very own Scientist Team led by Chief Medical Officer Dr. Ronnie Aronson and Senior Scientist Michael Riddell.This 2nd paper highlights that High...
